Heavy water labeling of keratin as a non-invasive biomarker of skin turnover in vivo in rodents and humans

Journal of Investigative Dermatology

Volumn 126, Issue 4, 2006, Pages 841-848

  Lindwall, Glen ^a   Hsieh, Elaine A ^a   Misell, Lisa M ^b   Chai, Christine M ^a   Turner, Scott M ^b   Hellerstein, Marc K ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KINEMED INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DEUTERIUM OXIDE; KERATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMICAL LABELING; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; KINETICS; MONITORING; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN; SKIN SURFACE; TURNOVER TIME;

ANIMALS; BIOLOGICAL MARKERS; DEUTERIUM OXIDE; HUMANS; KERATINOCYTES; KERATINS; MICE; MICE, INBRED C57BL; SKIN;

EID: 33645034938     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700189     Document Type: Article

References (50)

1. Achtstaetter T, Hatzfeld M, Quinlan RA, Parmelee DC, Franke WW (1986) Separation of cytokeratin polypeptides by gel electrophoretic and chromatographic techniques and their identification by immunoblotting. Methods Enzymol 134:355-71
2. Bayliffe AI, Brigandi RA, Wilkins HJ, Levick MP (2004) Emerging therapeutic targets in psoriasis. Curr Opin Pharmacol 4:306-10
3. Beamer WG, Pelsue SC, Shultz LD, Sundberg JP, Barker JE (1995) The flaky skin (fsn) mutation in mice: map location and description of the anemia. Blood 86:3220-6
4. Busch R, Kim Y, Neese RA, Schade-Serin V, Collins M, Awada M et al. (2006) Measurement of slow protein turnover rates by heavy water labeling via nonessential amino acids. Biochim Biphys Acta, in press
5. Collins M, Eng S, Hoh R, Hellerstein MK (2003) Measurement of mitochondrial DNA synthesis in vivo using a stable isotope-mass spectrometric technique. J Appl Physiol 94:2203-11
6. de Rie MA, Goedkoop AY, Bos JD (2004) Overview of psoriasis. Dermatol Ther 17:341-9
7. Dover R (1993) Cell kinetics of keratinocytes. In: The keratinocyte handbook (Leigh IM, Lane EB, Watt FM, eds), Cambridge: Cambridge University Press, 203-34
8. Epstein WL, Maibach HI (1965) Cell renewal in human epidermis. Arch Dermatol 92:462-8
9. Fanara P, Turner S, Busch R, Killion S, Awada M, Turner H et al. (2004) In vivo measurement of microtubule dynamics using stable isotope labeling with heavy water. J Biol Chem 279:49940-7
10. Fore-Pfliger J (2004) The epidermal skin barrier: implications for the wound care practitioner, part II. Adv Skin Wound Care 17:480-8
11. Fuchs E (1996) The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu Rev Genet 30:197-231
12. Gijbels MJ, Elliott GR, HogenEsch H, Zurcher C, van den Hoven A, Bruijnzeel PL (2000) Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Exp Dermatol 9:351-8
13. Grove GL, Kligman AM (1983) Age-associated changes in human epidermal cell renewal. J Gerontol 38:137-42
14. Haake A, Scott GA, Holbrook KA (2001) Structure and function of the skin: overview of the epidermis and dermis. In: The biology of the skin (Freinkel R, Woodley D, eds), New York: Parthenon Publishing, 19-45
15. Hatano Y, Terashi H, Arakawa S, Katagiri K (2005) Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol 124:786-92
16. Hellerstein MK, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5:83-9
17. Hellerstein MK, Hoh RA, Hanley MB, Cesar D, Lee D, Neese RA et al. (2003) Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 112:821-4
18. Hellerstein MK, Neese RA (1999) Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am J Physiol 276(Part 1):E1146-70
19. Hoath SB, Leahy DG (2003) The organization of human epidermis: functional epidermal units and phi proportionality. J Invest Dermatol 121:1440-6
20. Hsieh E, Chai CM, de Lumen BO, Neese RA, Hellerstein MK (2004) Dynamics of keratinocytes in vivo using HO labeling: a sensitive marker of epidermal proliferation state. J Invest Dermatol 123:530-6
21. Kim SJ, Cheung S, Hellerstein MK (2004) Isolation of nuclei from label-retaining cells and measurement of their turnover rates in rat colon. Am J Physiol Cell Physiol 286:C1464-73
22. Kirfel J, Magin TM, Reichelt J (2003) Keratins: a structural scaffold with emerging functions. Cell Mol Life Sci 60:56-71
23. Langley R, Ellis CN (2004) Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. J Am Acad Dermatol 51:563-9
24. Lebwohl M (2003) Psoriasis. Lancet 361:1197-204
25. Löffler H, Dreher F, Maibach HI (2004) Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol 151:746-52
26. Louden B, Pearce DJ, Lang W, Feldman SR (2004) A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J 10:7
27. McCune J, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D et al. (2000) Factors influencing T-cell turnover in HIV-1-seropositive patients. J Clin Invest 105:R1-8
28. Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 115:755-64
29. Miller DL (1995) Sticky slides and tape techniques to harvest stratum corneum. In: Handbook of non-invasive methods and the skin (Serup J, Jemec GBE, eds), Boca Raton, FL: CRC Press, Chapter 7.2
30. Misell L, Hwang ES, Au A, Esserman L, Hellerstein MK (2005) Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Breast Cancer Res Treat 89:257-64
31. Morita K, Hogan ME, Nanney LB, King LE Jr, Manabe M, Sun TT et al. (1995) Cutaneous ultrastructural features of the flaky skin (fsn) mouse mutation. J Dermatol 22:385-95
32. 2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci USA 99:15345-50
33. Neese RA, Siler SQ, Cesar D, Antelo F, Lee D, Misell L et al. (2001) Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Anal Biochem 298:189-95
34. Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664-75
35. Pelsue SC, Schweitzer PA, Schweitzer IB, Christianson SW, Gott B, Sundberg JP et al. (1998) Lymphadenopathy, elevated serum IgE levels, autoimmunity, and mast cell accumulation in flaky skin mutant mice. Eur J Immunol 28:1379-88
36. Pierard-Franchimont C, Pierard GE (1985) Skin surface stripping in diagnosing and monitoring inflammatory, xerotic, and neoplastic diseases. Pediatric Dermatol 2:180-4
37. Rothberg S, Crounse RG, Lee JL (1961) Glycine-C-14-incorporation into the proteins of normal stratum corneum and the abnormal stratum corneum of psoriasis. J Invest Dermatol 37:497-505
38. Rugg E, Leigh IM (2004) The keratins and their disorders. Am J Med Genet C Semin Med Genet 131C:4-11
39. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K et al. (2005) Sta3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9
40. Schön MP (1999) Animal models of psoriasis - what can we learn from them? J Invest Dermatol 112:405-10
41. 2O. Am J Physiol Endocrinol Metab 286:E577-88
42. Sundberg JP, Beamer WG, Shultz LD, Dunstan RW (1990) Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses. J Invest Dermatol 95:62S-3S
43. Sundberg JP, Boggess D, Shultz LD, Beamer WG (1994) The flaky skin (fsn) mutation, chromosome? In: Handbook of mouse mutations with skin and hair abnormalities (Sundberg JP, ed), Boca Raton, FL: CRC Press, Inc., 253-68
44. Sundberg JP, France M, Boggess D, Sundberg BA, Jenson AB, Beamer WG et al. (1997) Development and progression of psoriasiform dermatitis and systemic lesions in the flaky skin (fsn) mouse mutant. Pathobiology 65:271-86
45. Surber C, Schwarb FP, Smith EW (1999) Tape stripping technique. In: Percutaneous absorption: drugs-cosmetics-mechanisms-methodology (Bronaugh RL, Maibach HI, eds), 3rd ed, New York: Dekker
46. Watt FM (2002) Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21:3919-26
47. Weinstein GD, McCullough JL, Ross PA (1984) Cell proliferation in normal epidermis. J Invest Dermatol 82:623-8
48. Weinstein GD, McCullough JL, Ross PA (1985) Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol 85:579-83
49. Whitfield JF, Chakravarthy B (2001) Calcium: the grand-master cell signaler. Ottawa: NRC Research Press
50. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-8